Home | Welcome to Contract Pharma   
Last Updated Monday, March 2 2015

Print

Breaking News

March 2, 2015
Baim to oversee Pharma & Food Chemistry labs ops  Read More »
March 2, 2015
ALM201 is the company’s first clinical stage program  Read More »
March 2, 2015
Expands service team to support Latin American market  Read More »
March 2, 2015
Will research neo-antigen immunotherapy  Read More »
March 2, 2015
Advances Phase II/III study of ISIS-TTR in FAP  Read More »
March 2, 2015
Integrates continuous flow manufacturing technology  Read More »
February 27, 2015
Will offer production of API using microbial expression systems  Read More »
February 27, 2015
Goal is to identify best-in-class RORγ inhibitors to treat autoimmune disease  Read More »
February 27, 2015
Shifts production in-house after US FDA concerns about CMO Emcure  Read More »
February 27, 2015
New drug company launched by former CEO of Retrophin  Read More »
February 27, 2015
Increases cold storage capabilities at three sites  Read More »
February 26, 2015
Drouet brings 20 years of R&D experience  Read More »
February 26, 2015
Once-daily basal insulin requires a third of the injection volume as compared to the Lantus SoloSTAR  Read More »
February 26, 2015
Gains Phase IIa antiviral candidate AP611074  Read More »
February 26, 2015
Gains two late-stage assets, Dermadexin and Pruridexin  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On